Open Source Drug Discovery: Finding a Niche (or Maybe Several)

  title={Open Source Drug Discovery: Finding a Niche (or Maybe Several)},
  author={S. M. Maurer},
  journal={Product Innovation eJournal},
  • S. M. Maurer
  • Published 2007
  • Engineering
  • Product Innovation eJournal
Despite their novelty and importance, open source methods have been largely been limited to software. However, scholars have long suggested that it would be logical to organize at least one other field - drug discovery - using open source principles. This paper reviews today's relatively tentative attempts to organize open source biology collaborations and argues that more ambitious projects are feasible. Five specific projects are proposed and analyzed in detail. The article concludes by… Expand
Open source drug collaborations: a rational design approach.
This article reviews what economists have learned regarding the strengths and weaknesses of OS methods and identifies specific drug-discovery tasks where OS methods are likely to work especially well and offers detailed suggestions for how existing OS software models can be modified and extended to conduct effective drug discovery. Expand
A Kernel for Open Source Drug Discovery in Tropical Diseases
The TDI kernel provides a source of potential drug targets and drug candidates around which an online open source community can nucleate and will facilitate collaborative efforts towards the discovery of new drugs against parasites that cause tropical diseases. Expand
Common characteristics of open source software development and applicability for drug discovery: a systematic review
The open source model is viable for drug discovery, although it is unlikely that it will exactly follow the form used in software development. Expand
Is Open Science the Future of Drug Development?
  • Daniel L. Shaw
  • Business, Medicine
  • The Yale journal of biology and medicine
  • 2017
This perspective argues that while open science poses some risks—which include the management of collaboration and the protection of proprietary data—these strategies are, in many cases, the more efficient and ethical way to conduct biomedical research. Expand
A New Space for Biotechnology Innovation?: Comparison of Physical and Virtual Collaboration in Early Drug Discovery1
New technological opportunities and online communication constantly gain importance for knowledge integration and knowledge creation in any innovation-driven environment. The cooperation betweenExpand
Innovation for Drug Development in Neglected Diseases : A Case Study of India
Research and Innovation for Drug Development in Neglected Diseases: A Case Study of India Sujit Bhattacharya and Jayanthi A. Pushkaran Abstract This study investigated the research and innovation inExpand
Developing a Framework to Manage a Pharmaceutical Innovation Ecosystem: Collaboration Archetypes, Open Innovation Tools, and Strategies
Based on an in-depth case study of the ecosystem of one of the worlds largest healthcare companies including internal and external data collected since 2009, and through over 50 interviews with keyExpand
Where Does Open Science Lead Us During a Pandemic? A Public Good Argument to Prioritize Rights in the Open Commons
  • B. Capps
  • Medicine, Political Science
  • Cambridge Quarterly of Healthcare Ethics
  • 2020
It is argued that the open commons is a community of rights, consisting of people and institutions whose interests mutually support the public good, and unethical platforms ought to be excluded from the commons and its benefits. Expand
Promoting Access to Medical Technologies and Innovation - Intersections between public health, intellectual property and trade
=1086142. Council for International Organizations of Medical Sciences (CIOMS) (2016), International Ethical Guidelines for Healthrelated Research Involving Humans, Geneva: CIOMS. Creese, A. (2011),Expand
Open Science for private Interests? How the Logic of Open Science Contributes to the Commercialization of Research
It is argued that Open Science ends up contributing to the commercialization of science, instead of overcoming its limitations. Expand


Can open-source R&D reinvigorate drug research?
  • B. Munos
  • Medicine
  • Nature Reviews Drug Discovery
  • 2006
The low number of novel therapeutics approved by the US FDA in recent years continues to cause great concern about productivity and declining innovation. Can open-source drug research andExpand
Open Source Research — the Power of Us
Academic and industrial scientific research operate on powerful and complementary models, consisting of some mix of competitive funding, peer review, and limited inter-laboratory collaboration.Expand
The Penguin's Genome, or Coase and Open Source Biotechnology
Open source offers an interesting alternative to government control or private bargaining over rights to a commons. Open source production, however, will not occur on any significant scale absentExpand
The Open Source Biotechnology Movement: Is it Patent Misuse?
Fledgling efforts exist to establish open-source projects in biotechnology. Following copyleft, participants agree that advances in the technology must remain as openly available as the originalExpand
Commons-Based Strategies and the Problems of Patents
This Policy Forum reviews the experience of free software, distributed computing, and other forms of commons-based peer production and proposes two complementary avenues open to scientists and universities to alleviate the costs of overly protective patent systems. Expand
Harnessing and Sharing the Benefits of State-Sponsored Research: Intellectual Property Rights and Data Sharing in California's Stem Cell Initiative
In recent years data-sharing has been a recurring focus of struggle within the scientific research community as improvements in information technology and digital networks have expanded the ways thatExpand
Gene-function wiki would let biologists pool worldwide resources
A ‘gene function’ equivalent of Wikipedia is proposed for science, where the average biologist has little notion as to what most of them do, and has to start ploughing through the literature. Expand
Finding Cures for Tropical Diseases: Is Open Source an Answer?
The Tropical Disease Initiative will be a Web-based, community- wide effort where scientists from the public and private sectors join together to discover new treatments
The Major Role of Clinicians in the Discovery of Off‐Label Drug Therapies
The role of clinicians in the discovery of off‐label use of prescription drugs approved by the United States Food and Drug Administration is investigated. Expand
Is the Pharmaceutical Industry in a Productivity Crisis?
  • I. Cockburn
  • Economics
  • Innovation Policy and the Economy
  • 2006
Rising R&D expenditures and falling counts of new drug approvals since 1996 have lead many observers to conclude that there has been a sharp decline in research productivity in the pharmaceuticalExpand